You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
McKesson
Moodys
Merck

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pheniramine


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Pheniramine?

Pheniramine is an investigational drug.

There have been 33 clinical trials for Pheniramine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 5th 2018.

The most common disease conditions in clinical trials are Rhinitis, Rhinitis, Allergic, and Hypersensitivity. The leading clinical trial sponsors are Mantecorp Industria Quimica e Farmaceutica Ltd., EMS, and National Cancer Center, Korea.

There is one US patent protecting this investigational drug and eleven international patents.

Recent Clinical Trials for Pheniramine
TitleSponsorPhase
Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative EndoscopySeoul National University HospitalN/A
Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical ResearchChina Medical University HospitalN/A
Effect of Anti-histamine in Prevention Systolic Hypotension After ProtamineMahidol UniversityPhase 4

See all Pheniramine clinical trials

Clinical Trial Summary for Pheniramine

Top disease conditions for Pheniramine
Top clinical trial sponsors for Pheniramine

See all Pheniramine clinical trials

US Patents for Pheniramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pheniramine   Start Trial Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA)   Start Trial
Pheniramine   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
Pheniramine   Start Trial Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY)   Start Trial
Pheniramine   Start Trial Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pheniramine

Drugname Country Document Number Estimated Expiration Related US Patent
Pheniramine Australia 2014232383 2033-03-15   Start Trial
Pheniramine Australia 2019202731 2033-03-15   Start Trial
Pheniramine Brazil 112015023267 2033-03-15   Start Trial
Pheniramine Canada 2906931 2033-03-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Express Scripts
Johnson and Johnson
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.